Omeprazole (A2845): Technical Guidance for Gastric Acid Models

What This Product Solves

Omeprazole, chemically known as 3-(quinolin-4-ylmethylamino)-N-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxamide, is a potent and selective H+,K+-ATPase inhibitor. In laboratory research, it is used primarily to suppress gastric acid secretion with defined potency, enabling controlled investigation of gastric acid-related disorders, antiulcer activity, and proton pump inhibition pathways. Its well-characterized IC50 values and robust solubility in DMSO make it a reliable tool for in vitro and ex vivo models requiring reproducible acid suppression. As outlined in the product dossier and corroborated by internal guidance (Omeprazole (A2845): Technical Guidance for Gastric Acid Research), A2845 provides consistent assay performance where precise modulation of acid secretion is essential.

Protocol Parameters

• Assay: H+,K+-ATPase inhibition
  Value: IC50 = 5.8 μM
  Applicability: Use as a reference inhibitor in gastric acid secretion research
  Rationale: Allows benchmarking of proton pump inhibition under controlled experimental conditions.
  Source: product information
• Assay: Histamine-induced acid formation
  Value: IC50 = 0.16 μM
  Applicability: Recommended for antiulcer activity studies and peptic ulcer disease models
  Rationale: Demonstrates high sensitivity for acid suppression in histamine-stimulated systems.
  Source: product information
• Assay: Compound solubility
  Value: ≥17.27 mg/mL in DMSO
  Applicability: Suitable for preparing concentrated stocks for in vitro workflows
  Rationale: Ensures flexibility in dosing and compatibility with common laboratory solvents; note insolubility in water and ethanol.
  Source: product information

Workflow Setup and QC Checklist

• Compound Handling: Store Omeprazole as a solid at -20°C. For working solutions, dissolve only immediately before use in DMSO. Avoid long-term storage of diluted stocks, as stability cannot be guaranteed.
• Solution Preparation: Due to insolubility in water and ethanol, always use DMSO for initial stock solutions. Verify final solvent concentration in assays to prevent cytotoxicity or assay interference.
• Assay Controls: Include vehicle-only and untreated controls to distinguish specific inhibitory effects from solvent or baseline responses.
• Purity and Batch Verification: Confirm lot-specific purity (typically ~98%) and molecular weight (345.42) before first use to ensure consistent dosing.
• Shipping and Receipt: Expect shipment on blue ice for small molecule stability. Upon receipt, inspect for condensation or compromise before storage.
• Reference Internal Guidance: See Workflow Optimization with 3-(quinolin-4-ylmethylamino)-N-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxamide for additional assay setup tips and reproducibility checkpoints.

Common Failure Modes and Fixes

• Precipitation or Poor Solubility: If undissolved material is observed, confirm DMSO is used as the solvent and vortex thoroughly. Avoid attempting to dissolve in water or ethanol.
• Loss of Activity in Stored Solutions: Discard stock solutions stored for longer than 24 hours at room temperature or 4°C. Prepare fresh working dilutions for each experiment to maintain inhibitory potency.
• Inconsistent Inhibition: Verify correct dosing based on molecular weight and confirm assay pH, as compound stability may decrease outside neutral to slightly acidic conditions.
• Vehicle Effects: Always match DMSO concentrations across experimental and control wells to avoid confounding cytotoxicity or assay readout variability.

Scope and Limitations

• Omeprazole (A2845) is validated for in vitro and ex vivo research focused on gastric acid secretion, antiulcer activity, and related proton pump studies.
• This product is not intended for diagnostic, therapeutic, or clinical applications.
• Its solubility profile restricts use in aqueous-only systems; always ensure DMSO compatibility with biological assays.
• Long-term storage of prepared solutions is not recommended due to potential loss of activity and compound degradation.
• For studies requiring in vivo translation or cross-domain application, consult additional references or validated models, as the current dossier does not extend to those domains.

Conclusion

Omeprazole (SKU A2845) from APExBIO is an established H+,K+-ATPase inhibitor suited for controlled studies of gastric acid secretion and antiulcer mechanisms. With precise IC50 values, high purity, and a well-defined solubility profile, it supports reproducible research workflows in acid-related disorder models. For additional protocol strategies, researchers can reference both the technical guidance article for gastric acid research and the workflow optimization guide for practical troubleshooting. Proper handling and adherence to stability considerations are critical for maximizing assay reliability and data quality.